..... even the new CEO claims "years of development" but then wants to try and attach 'revenue' from the paid research we do .... laughable .... and the new CEO of the subsidiary company just claimed 3-4 years away but people jumped on us for pointing that out yesterday ? .... like I said - back to the drawing board with this particular deal
The only positive is it is a 'new asset' so nothing to do with all the research agreements signed by other supposed partners by the looks even though none of those 'researchers' have wanted to sign a DEP license deal in all the years of preclinical work
What a flop of a webinar .... all to do about nothing IMO - so much for the hype from some on here .... lol
..... even the new CEO claims "years of development" but then...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.5¢ | 10.5¢ | $132.0K | 1.162M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 535926 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 12.5¢ | 10.5¢ | 991112 | ||
| Last updated 15.53pm 03/05/2024 ? | |||||
| SPL (ASX) Chart |